VGF nerve growth factor inducible, named for its discovery as a rapidly induced gene product following nerve growth factor stimulation, is a secreted polypeptide precursor that plays a critical role in the nervous system and beyond. Functionally, VGF is involved in neurogenesis, synaptic plasticity, energy metabolism, and the regulation of mood and behavior. Its activity is crucial for neuronal development, survival, and adaptation to environmental stresses. The peptides from the proteolytic processing of the VGF precursor are implicated in a myriad of physiological processes, including the modulation of synaptic transmission, control of energy homeostasis, and response to stress, which highlights the broad functional spectrum of VGF in maintaining neural and systemic health.
The activation of VGF is tightly regulated at multiple levels, beginning with transcriptional activation in response to neurotrophic factors such as NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). This induction signifies the involvement of VGF in neurotrophin signaling pathways, which are essential for neuronal growth and the plasticity of neural circuits. Following transcription, the VGF precursor protein undergoes extensive post-translational processing, including proteolytic cleavage to generate active peptides that exert various biological effects. This processing is essential for the activation of VGF-derived peptides, allowing for the targeted modulation of physiological processes. Furthermore, the secretion of VGF peptides is regulated by neuronal activity and is dependent on calcium levels, which ensures that the release of active peptides is precisely coordinated with neuronal signaling and environmental cues. Through these mechanisms, the activation of VGF contributes to the dynamic regulation of neuronal function, energy balance, and stress response, underscoring its integral role in the complex interplay between the nervous system and overall physiological homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to increased cAMP levels, which can stimulate VGF gene expression indirectly. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), activating VGF expression through PKC-mediated signaling pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cell-permeable analog of cAMP that can directly activate cAMP-dependent pathways and VGF gene expression. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
An ionophore that raises intracellular calcium levels, potentially activating calcium-dependent pathways related to VGF. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
An inhibitor of phosphodiesterase 4 (PDE4), increasing intracellular cAMP levels and indirectly activating VGF expression. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Activates beta-adrenergic receptors, leading to cAMP production and potential activation of VGF expression. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
Activates muscarinic acetylcholine receptors, potentially activating VGF expression through intracellular signaling. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
An L-type calcium channel activator that can increase intracellular calcium levels, potentially affecting VGF-related pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Activates EP2 and EP4 receptors, leading to increased cAMP levels and potential activation of VGF gene expression. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMP-activated protein kinase (AMPK), activating VGF expression through the AMPK pathway. | ||||||